Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.8%
    Check dated 2024-09-04T06:30:33.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-08-28T03:36:04.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-08-21T02:24:59.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-14T01:05:03.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-08-07T00:02:09.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-07-30T23:49:12.000Z thumbnail image

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.